Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1990 Oct;71(2):236–241.

Thrombin and factor Xa enhance the production of interleukin-1.

A Jones 1, C L Geczy 1
PMCID: PMC1384310  PMID: 2228024

Abstract

Interleukin-1 (IL-1) plays a major role in inflammatory responses. Activation of coagulation and fibrin deposition typical of these reactions is mediated by macrophage procoagulants induced on stimulated macrophages. IL-1 activity in the supernatant of lipopolysaccharide (LPS)-stimulated guinea-pig macrophages was markedly enhanced by the presence of thrombin during macrophage activation. Although thrombin alone had no effect, inclusion of 1 mU/ml of thrombin with suboptimal levels of LPS produced a 200-fold increase in IL-1 activity, and further enhancement was observed with increasing doses of thrombin. The active site of thrombin was necessary for enhancement, as the serine esterase inhibitor di-isopropyl-fluorophosphate (DIP) and hirudin inhibited the synergy observed with LPS and thrombin. Prothrombin and Factor Xa also enhanced IL-1 production, although not to the same extent as thrombin. Factor Xa-like activity was demonstrated on the surface of LPS-stimulated macrophages. Both the Xa-like activity and IL-1 generated by LPS-stimulated cells were inhibited by heparin. Heparin with a high affinity for antithrombin III (anti-coagulant heparin; HAH) inhibited IL-1 generation, whereas low-affinity heparin (non-anticoagulant; LAH) had no effect. We show that proteases of the extrinsic coagulation cascade enhance IL-1 generation and propose that a Factor Xa-like activity present in activated macrophages, together with thrombin, may be important in IL-1 processing.

Full text

PDF
236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auron P. E., Warner S. J., Webb A. C., Cannon J. G., Bernheim H. A., McAdam K. J., Rosenwasser L. J., LoPreste G., Mucci S. F., Dinarello C. A. Studies on the molecular nature of human interleukin 1. J Immunol. 1987 Mar 1;138(5):1447–1456. [PubMed] [Google Scholar]
  2. Auron P. E., Webb A. C., Rosenwasser L. J., Mucci S. F., Rich A., Wolff S. M., Dinarello C. A. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7907–7911. doi: 10.1073/pnas.81.24.7907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Björk I., Lindahl U. Mechanism of the anticoagulant action of heparin. Mol Cell Biochem. 1982 Oct 29;48(3):161–182. doi: 10.1007/BF00421226. [DOI] [PubMed] [Google Scholar]
  4. Broze G. J., Jr Binding of human factor VII and VIIa to monocytes. J Clin Invest. 1982 Sep;70(3):526–535. doi: 10.1172/JCI110644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clement L. T., Yamashita U., Shevach E. M. Characterization of an antiserum to guinea pig antithrombin III (AT III). I. Reactivity with guinea pig T lymphocytes. J Immunol. 1981 Sep;127(3):1220–1227. [PubMed] [Google Scholar]
  6. Cohen S., Benacerraf B., McCluskey R. T., Ovary Z. Effect of anticoagulants on delayed hypersensitivity reactions. J Immunol. 1967 Feb;98(2):351–358. [PubMed] [Google Scholar]
  7. Conlon P. J., Grabstein K. H., Alpert A., Prickett K. S., Hopp T. P., Gillis S. Localization of human mononuclear cell interleukin 1. J Immunol. 1987 Jul 1;139(1):98–102. [PubMed] [Google Scholar]
  8. Currie G. A. Effect of heparin on mixed lymphocyte cultures. Nature. 1967 Jul 8;215(5097):164–165. doi: 10.1038/215164a0. [DOI] [PubMed] [Google Scholar]
  9. Dean R. T., Leoni P., Rossi B. C. Regulation of procoagulant factors in mononuclear phagocytes. Haemostasis. 1984;14(5):412–421. doi: 10.1159/000215099. [DOI] [PubMed] [Google Scholar]
  10. Dinarello C. A. Biology of interleukin 1. FASEB J. 1988 Feb;2(2):108–115. [PubMed] [Google Scholar]
  11. Dinarello C. A. Multiple biological properties of recombinant human interleukin 1 (beta). Immunobiology. 1986 Sep;172(3-5):301–315. doi: 10.1016/S0171-2985(86)80112-7. [DOI] [PubMed] [Google Scholar]
  12. Frieri M., Metcalfe D. D. Analysis of the effect of mast cell granules on lymphocyte blastogenesis in the absence and presence of mitogens: identification of heparin as a granule-associated suppressor factor. J Immunol. 1983 Oct;131(4):1942–1948. [PubMed] [Google Scholar]
  13. Geczy C. L. The role of lymphokines in delayed-type hypersensitivity reactions. Springer Semin Immunopathol. 1984;7(4):321–346. doi: 10.1007/BF00201965. [DOI] [PubMed] [Google Scholar]
  14. Gray P. W., Glaister D., Chen E., Goeddel D. V., Pennica D. Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta. J Immunol. 1986 Dec 1;137(11):3644–3648. [PubMed] [Google Scholar]
  15. Hogg N. Human monocytes have prothrombin cleaving activity. Clin Exp Immunol. 1983 Sep;53(3):725–730. [PMC free article] [PubMed] [Google Scholar]
  16. Kurt-Jones E. A., Beller D. I., Mizel S. B., Unanue E. R. Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1204–1208. doi: 10.1073/pnas.82.4.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Larrick J. W., Kunkel S. L. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response. Pharm Res. 1988 Mar;5(3):129–139. doi: 10.1023/a:1015904721223. [DOI] [PubMed] [Google Scholar]
  18. Lepe-Zuniga J. L., Gery I. Production of intra- and extracellular interleukin-1 (IL-1) by human monocytes. Clin Immunol Immunopathol. 1984 May;31(2):222–230. doi: 10.1016/0090-1229(84)90242-3. [DOI] [PubMed] [Google Scholar]
  19. Lepe-Zuniga J. L., Zigler J. S., Jr, Zimmerman M. L., Gery I. Differences between intra- and extracellular interleukin-1. Mol Immunol. 1985 Dec;22(12):1387–1392. doi: 10.1016/0161-5890(85)90061-6. [DOI] [PubMed] [Google Scholar]
  20. Leung L., Saigo K., Grant D. Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein. Blood. 1989 Jan;73(1):177–184. [PubMed] [Google Scholar]
  21. Levin E. G., Loskutoff D. J. Serum-mediated suppression of cell-associated plasminogen activator activity in cultured endothelial cells. Cell. 1980 Dec;22(3):701–707. doi: 10.1016/0092-8674(80)90546-2. [DOI] [PubMed] [Google Scholar]
  22. Lindahl U., Kolset S. O., Bøgwald J., Osterud B., Seljelid R. Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages. Biochem J. 1982 Aug 15;206(2):231–237. doi: 10.1042/bj2060231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lomedico P. T., Gubler U., Hellmann C. P., Dukovich M., Giri J. G., Pan Y. C., Collier K., Semionow R., Chua A. O., Mizel S. B. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. 1984 Nov 29-Dec 5Nature. 312(5993):458–462. doi: 10.1038/312458a0. [DOI] [PubMed] [Google Scholar]
  24. Lyberg T. Clinical significance of increased thromboplastin activity on the monocyte surface--a brief review. Haemostasis. 1984;14(5):430–439. doi: 10.1159/000215101. [DOI] [PubMed] [Google Scholar]
  25. Matsushima K., Taguchi M., Kovacs E. J., Young H. A., Oppenheim J. J. Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. J Immunol. 1986 Apr 15;136(8):2883–2891. [PubMed] [Google Scholar]
  26. Minnich-Carruth L. L., Suttles J., Mizel S. B. Evidence against the existence of a membrane form of murine IL-1 alpha. J Immunol. 1989 Jan 15;142(2):526–530. [PubMed] [Google Scholar]
  27. Mizel S. B. Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1). Mol Immunol. 1980 May;17(5):571–577. doi: 10.1016/0161-5890(80)90155-8. [DOI] [PubMed] [Google Scholar]
  28. Moon D. K., Geczy C. L. Recombinant IFN-gamma synergizes with lipopolysaccharide to induce macrophage membrane procoagulants. J Immunol. 1988 Sep 1;141(5):1536–1542. [PubMed] [Google Scholar]
  29. NELSON D. S. Reaction to antigens in vivo of the peritoneal macrophages of guinea-pigs with delayed type hypersensitivity. Effects of anticoagulants and other drugs. Lancet. 1963 Jul 27;2(7300):175–176. doi: 10.1016/s0140-6736(63)92808-3. [DOI] [PubMed] [Google Scholar]
  30. Nathan C. F. Secretory products of macrophages. J Clin Invest. 1987 Feb;79(2):319–326. doi: 10.1172/JCI112815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ottaway C. A., Warren R. E., Saibil F. G., Fung L. S., Fair D. S., Levy G. A. Monocyte procoagulant activity in Whipple's disease. J Clin Immunol. 1984 Sep;4(5):348–358. doi: 10.1007/BF00917137. [DOI] [PubMed] [Google Scholar]
  32. Ryan J., Geczy C. Coagulation and the expression of cell-mediated immunity. Immunol Cell Biol. 1987 Apr;65(Pt 2):127–139. doi: 10.1038/icb.1987.14. [DOI] [PubMed] [Google Scholar]
  33. Schwartz B. S., Levy G. A., Fair D. S., Edgington T. S. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med. 1982 May 1;155(5):1464–1479. doi: 10.1084/jem.155.5.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schwartz B. S., Monroe M. C., Levin E. G. Increased release of plasminogen activator inhibitor type 2 accompanies the human mononuclear cell tissue factor response to lipopolysaccharide. Blood. 1988 Mar;71(3):734–741. [PubMed] [Google Scholar]
  35. Stern D. M., Knitter G., Kisiel W., Nawroth P. P. In vivo evidence of intravascular binding sites for coagulation factor IX. Br J Haematol. 1987 Jun;66(2):227–232. doi: 10.1111/j.1365-2141.1987.tb01303.x. [DOI] [PubMed] [Google Scholar]
  36. Tracy P. B., Rohrbach M. S., Mann K. G. Functional prothrombinase complex assembly on isolated monocytes and lymphocytes. J Biol Chem. 1983 Jun 25;258(12):7264–7267. [PubMed] [Google Scholar]
  37. Tsao B. P., Fair D. S., Curtiss L. K., Edgington T. S. Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity. J Exp Med. 1984 Apr 1;159(4):1042–1057. doi: 10.1084/jem.159.4.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yamashita U., Clement L. T., Shevach E. M. Characterization of an antiserum to guinea pig antithrombin III (AT III). II. Stimulation of T lymphocyte proliferation. J Immunol. 1981 Sep;127(3):1228–1231. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES